Skip to: Curated Story Group 1
Visually Open Nav.
Advertise
with us
US
EUROPE
APAC
CANADA
LATAM
subscribe
Open Search Field.
Home
Topics
Biomanufacturing
Biomanufacturing
Biomanufacturing
Biomanufacturing
Biomanufacturing
Business Services
Business Services
Business Services
Business Services
Business Services
Drug Discovery
Drug Discovery
Drug Discovery
Drug Discovery
Drug Discovery
Pharmacy Management
Regulatory Services
CXO Insights
Vendor Viewpoint
News
Conferences
Newsletter
Whitepapers
Magazine
CXO Awards
AUGUST 2024LIFE SCIENCES REVIEW6The future of biotechnology is advancing with smaller, faster, and more precise tools. From microscopic machines shaping life's building blocks to mobile ecosystems processing waste, biotech startups are innovating healthcare and sustainability. The Hydroporator, a pioneering advancement in microfluidic cellular engineering, is transforming cell therapy. This platform efficiently delivers diverse cargos--plasmid DNA, mRNA, proteins, CRISPR-Cas9 RNPs and nanoparticles--into primary cells, ensuring viability and function. Its high efficiency, speed, scalability and clinical potential mark a significant leap forward in biotherapy. Another recent innovation is the mobile bio-conversion system, which is revolutionizing decentralized organic waste management. Using black soldier fly larvae in a compact shipping container, it converts food and organic waste into insect protein and fertilizer. Integrating advanced technologies, machinery, equipment and IoT sensors, this system efficiently manages raw food waste, presenting a sustainable approach to waste processing.The global biotechnology market is poised for a staggering surge, with a projected CAGR of 13.96 percent, propelling its value from $1.55 trillion in 2023 to even greater heights by 2030. This edition of the Life Sciences Review APAC offers insights into the latest trends in biotechnology startups and how companies are aligning with them. Stay informed as industry leaders share their experiences and strategies for navigating the evolving landscape of biotechnology standards and the growing demand for more user-friendly practices. The magazine features a thought-provoking article from Johnny Yu, Managing Director at Mosaic Venture Lab. He emphasizes navigating early-stage investments requires understanding technology, startup jargon and assessing intangible metrics like patents to minimize risks and foster mutual benefit. It also includes an article by Narayana Rao, Vice President of Biopharma, Asia Pacific Middle-East Africa, Avantor, where he sheds light on the rapid growth of cell and gene therapy demanding innovative bio-manufacturing solutions and strategic collaborations to overcome scalability challenges and optimize production efficiency. In this edition of Life Sciences Review APAC, we also feature Top Biotech Startups in APAC 2024, and we hope you find the right partner to meet your organization's needs. Let us know your thoughts! EDITORIALBioinnovations for a Healthier Future Copyright © 2024 ValleyMedia, Inc. All rights reserved. Reproduction in whole or part of any text, photography or illustrations without written permission from the publisher is prohibited. The publisher assumes no responsibility for unsolicited manuscripts, photographs or illustrations. Views and opinions expressed in this publication are not necessarily those of the magazine and accordingly, no liability is assumed by the publisher thereof.Editorial StaffAaron PierceCarolynn WaltersShirley FaithRussell ThomasGilbert HooverAncel CastelinoDisclaimer: *Some of the Insights are based on our interviews with CIOs and CXOsJeremy WilliamsManaging Editoreditor@lifesciencesreview.comManaging EditorJeremy WilliamsAUGUST - 01 - 2024, Vol 05, Issue - 17 (ISSN 2831-8331) Published by ValleyMedia, Inc.To subscribe to Life Sciences ReviewVisit www.lifesciencesreview.com VisualizersHenry SmithVictor Cruz Email:sales@lifesciencesreview.comeditor@lifesciencesreview.commarketing@lifesciencesreview.com
<
Page 5
|
Page 7
>